Antimicrobial peptide CEC-TY1: a potential antibacterial drug against carbapenem-resistant Klebsiella pneumoniae
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.00543-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Yaozhu Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Anti-Bacterial Agents, Klebsiella Infections, Antimicrobial Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in hospitals and the issues arising from their rapid spread have become significant public health challenges. Therefore, a new class of effective and safe antibacterial drugs is urgently required. In this study, we identified an antimicrobial peptide in the cecropin family, cecropin-TY1 (CEC-TY1), from the salivary glands of the horsefly. CEC-TY1 showed significant antibacterial activity against gram-negative bacteria, at concentrations up to 100 μg/mL, with no observed cytotoxicity or hemolytic activity against cells. Moreover, CEC-TY1 protected mice from lethal infections of CRKP in vivo , improving the survival rate of the infected mice. This peptide also alleviated excessive and harmful inflammatory responses by inhibiting the production of interleukin (IL)-6, tumor necrosis factor-α, and IL-1β. IMPORTANCE Antimicrobial peptides are a promising alternative to antibiotics in the current antibiotic resistance crisis. Specifically, the antimicrobial peptide cecropin-TY1 (CEC-TY1), identified in the salivary glands of horseflies, showed significant antibacterial activity against carbapenem-resistant Klebsiella pneumoniae (CRKP), both in vitro and in vivo . CEC-TY1 also has selective toxicity and low hemolytic activity and is therefore a potential therapeutic agent for acute CRKP infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Yunnan Key Laboratory of Laboratory Medicine, Kunming, China.
- Yunnan Province Clinical Research Center for Laboratory Medicine, Kunming, China.
- School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan, China.
ORCID-Profile: Yaozhu Yang, Yongshi Zhao, Shumin Liu, Yan Du
Zitieren
APA
Yang, Y., Yang, H., He, Q., Niu, M., Yang, K., Zhao, Y., Liu, S., & Du, Y. (2025). Antimicrobial peptide CEC-TY1: a potential antibacterial drug against carbapenem-resistant Klebsiella pneumoniae. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00543-25
Vancouver
Yang Y, Yang H, He Q, Niu M, Yang K, Zhao Y, et al. Antimicrobial peptide CEC-TY1: a potential antibacterial drug against carbapenem-resistant Klebsiella pneumoniae. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00543-25
BibTeX
@article{Yang2025,
author = {Yang, Yaozhu and Yang, Hailong and He, Qiuyue and Niu, Min and Yang, Kai and Zhao, Yongshi and Liu, Shumin and Du, Yan},
title = {Antimicrobial peptide CEC-TY1: a potential antibacterial drug against carbapenem-resistant Klebsiella pneumoniae},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.00543-25}
}
EUVIMED